Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Moore/TPL Commercialization Agreement

The Moore/TPL Commercialization Agreement

posted on May 13, 2009 04:19AM
Share
New Message
Please login to post a reply